TY - JOUR
T1 - microRNAs and the immune response
AU - Tsitsiou, Eleni
AU - Lindsay, Mark A
PY - 2009
Y1 - 2009
N2 - Although the immune response is predominantly controlled at the transcriptional level, microRNA-mediated RNA interference is emerging as an important regulatory mechanism that operates at the translation level. Specifically, recent studies indicate that those miRNAs that are selectively and/or highly expressed in immune cells including the miR-17–92 cluster, miR-150, miR-155, miR-181 and miR-223 have a ‘permissive’ function in the maturation, proliferation and differentiation of myeloid and lymphoid cells. Importantly, these actions of miRNAs often involve interactions with transcription factors. In contrast, the rapid and transient induction of miR-9, miR-146a and miR-155 has been speculated to negatively regulate the acute responses following activation of innate immune through down-regulation of proteins involved in the receptor-induced signalling pathways.
AB - Although the immune response is predominantly controlled at the transcriptional level, microRNA-mediated RNA interference is emerging as an important regulatory mechanism that operates at the translation level. Specifically, recent studies indicate that those miRNAs that are selectively and/or highly expressed in immune cells including the miR-17–92 cluster, miR-150, miR-155, miR-181 and miR-223 have a ‘permissive’ function in the maturation, proliferation and differentiation of myeloid and lymphoid cells. Importantly, these actions of miRNAs often involve interactions with transcription factors. In contrast, the rapid and transient induction of miR-9, miR-146a and miR-155 has been speculated to negatively regulate the acute responses following activation of innate immune through down-regulation of proteins involved in the receptor-induced signalling pathways.
UR - http://www.scopus.com/inward/record.url?scp=68849125485&partnerID=8YFLogxK
UR - http://dx.doi.org/10.1016/j.coph.2009.05.003
U2 - 10.1016/j.coph.2009.05.003
DO - 10.1016/j.coph.2009.05.003
M3 - Article
SN - 1471-4892
VL - 9
SP - 514
EP - 520
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
IS - 4
ER -